Acadia Pharmaceuticals | ACAD - Операционный доход

Биржевая цена
20.98
Изменение за день
-0.01 -0.05%
Ежемесячно
-15.98%
Ежегодный
22.62%
Q1 прогноз
20.12




Операционный доход Изменить Дата
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Cara Therapeutics USD -2.39M 3.49M 2025-03
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Cytokinetics USD -178.37M 11.61M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Incyte USD 383.88M 47.43M 2025-12
J&J USD 5.59B 1.81B 2025-12
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Prothena USD -27.21M 12.55M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12